Deepak Khuntia, Member Board of Trustees and Chair of Corporate Research Forum at Radiation Oncology Institute (ROI), Radiation Oncologist at PCS Medical Group, SVP & Chief Medical Officer, Varian at Siemens Healthineers, shared a post on LinkedIn:
“Congrats to Dr. Daugherty and the Cincinnati team for achieving a major milestone in FLASH radiotherapy.
The study results support the safety and effectiveness of proton FLASH RT for thoracic bone metastasis. 100% of patients on the study had pain response (6 of 8 with complete pain response we and 2 of 8 with partial pain response).”
To which Sushil Beriwal, Vice President of Varian Medical Affairs, added:
“Taking flash clinical trials to next level with FLASH 02.”
Other articles featuring Deepak Khuntia and Sushil Beriwal on OncoDaily.